TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7919965

Group type: EXPERIMENTAL
Intervention: Immunotherapy with IFN-alpha and IL-2
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (surgery or chemotherapy)
Number of subjects: 72
Study: 3290263

Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg twice a day
Number of subjects: 20
Study: 31319002

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 307318

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 307318
Study: 30171747

Group type: EXPERIMENTAL
Intervention: High-dose metformin monotherapy (HMET) 1,500 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-dose metformin/linagliptin combination therapy (LMET + DPP4) 750 mg metformin + 5 mg linagliptin
Number of subjects: 11
Study: 28462861

Group type: EXPERIMENTAL
Intervention: 12-week training intervention
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Participation in sport activities at baseline
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Self-rated health
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Low education (<10 years)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Age <50 years
Number of subjects: 214
Study: 25882200

Group type: EXPERIMENTAL
Intervention: Video plus verbal feedback
Number of subjects: 32

Group type: COMPARATOR
Intervention: Verbal feedback
Number of subjects: 32

Group type: COMPARATOR
Intervention: Experiential feedback
Number of subjects: 32
Study: 24132374

Group type: EXPERIMENTAL
Intervention: Pulse wave velocity (PWV) measurement
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: High white matter hyperintensity (WMH) burden
Number of subjects: 91
Study: 21712672

Group type: EXPERIMENTAL
Intervention: Low-dose low-molecular weight heparin (LMWH)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Long compression stockings
Number of subjects: 75
Study: 19291301

Group type: EXPERIMENTAL
Intervention: Fixed-dose AS (25 mg)/AQ (67.5 mg)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Loose AS (50 mg) + AQ (153 mg)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Fixed-dose AS/AQ
Number of subjects: 750

Group type: COMPARATOR
Intervention: Loose AS+AQ
Number of subjects: 750
Study: 17355631

Group type: EXPERIMENTAL
Intervention: Ganciclovir treatment for 21 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: No antiviral treatment (Control)
Number of subjects: 12
Study: 15386322

Group type: EXPERIMENTAL
Intervention: Non-penetrating clips
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 98
Study: 11208219

Group type: EXPERIMENTAL
Intervention: Newspaper advertisements
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Community referrals
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Radio advertisements
Number of subjects: 138

Group type: COMPARATOR
Intervention: Public television
Number of subjects: 138

Group type: COMPARATOR
Intervention: Local posters
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Community colleges
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Press releases
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Community electronic sign
Number of subjects: 138
Study: 9689189

Group type: EXPERIMENTAL
Intervention: Ipriflavone, 200 mg three times daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 8279371

Group type: EXPERIMENTAL
Intervention: Anistreplase (APSAC) 30 U/5 min
Number of subjects: 182

Group type: COMPARATOR
Intervention: Alteplase (rt-PA) 100 mg/3 hours (adjusted for body weight < 65 kg)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Heparin (dose adjusted to maintain therapeutic partial thromboplastin time)
Number of subjects: 182
Study: 2638321

Group type: EXPERIMENTAL
Intervention: Glycine-fortified ORS at a concentration of 111 mmol/L (8.4 g/L)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard WHO-ORS
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycine-fortified ORS
Number of subjects: 50
Study: 1057645

Group type: EXPERIMENTAL
Intervention: Subgingival curettage
Number of subjects: 82

Group type: COMPARATOR
Intervention: Modified Widman flap surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pocket elimination
Number of subjects: 82

Group type: COMPARATOR
Intervention: All methods
Number of subjects: 82
Study: 30742834

Group type: EXPERIMENTAL
Intervention: 200 mg MB‐MMX
Number of subjects: 1205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1205
Study: 30004915

Group type: EXPERIMENTAL
Intervention: 12-week RESTORE program (exercise training, dietary counseling, and multidisciplinary education)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 43
Study: 27998849

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting nitinol stents (PES)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bare metal nitinol stents (BMS)
Number of subjects: 28
Study: 24673054

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with bloodletting
Number of subjects: 160

Group type: COMPARATOR
Intervention: Loratadine (10 mg, once a day)
Number of subjects: 160
Study: 22764339

Group type: EXPERIMENTAL
Intervention: One‐wave laser irradiation (810 nm, 8 J/point)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Two‐wave MLS laser irradiation (1100 mW, 2000 Hz, 12.4 J/point)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Two‐wave MLS laser irradiation (dose 6.6 J/point)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo group (simulated laser therapy without actual irradiation)
Number of subjects: 125
Study: 20395003

Group type: EXPERIMENTAL
Intervention: Braithwaite protocol
Number of subjects: 120

Group type: COMPARATOR
Intervention: simple sliding scale
Number of subjects: 120
Study: 17617942

Group type: EXPERIMENTAL
Intervention: Low-glycaemic index (LGI) diet
Number of subjects: 38

Group type: COMPARATOR
Intervention: High-glycaemic index (HGI) diet
Number of subjects: 38
Study: 16214482

Group type: COMPARATOR
Intervention: Gastrocnemius-Soleus (GS) muscle force-angle relation in SCI subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gastrocnemius-Soleus (GS) knee (GSK) force-angle measurements in SCI subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tibialis Anterior (TA) muscle force-angle relation in SCI subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Range of motion (ROM) in dorsiflexion direction in SCI subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Range of motion (ROM) in plantar flexion direction in SCI subjects
Number of subjects: 20
Study: 11849576

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1 mg x ml(-1)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg x ml(-1)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ropivacaine 3 mg x ml(-1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 110
Study: 10745613

Group type: EXPERIMENTAL
Intervention: Collagen plugging with VasoSeal
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (manual compression)
Number of subjects: 150
Study: 8775899

Group type: EXPERIMENTAL
Intervention: No. 8 silastic feeding tube for bladder drainage
Number of subjects: 146
Study: 1974533

Group type: EXPERIMENTAL
Intervention: Falope ring
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clip
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pomeroy ligation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Electrocoagulation
Number of subjects: 100
Study: 6991196

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31300051

Group type: EXPERIMENTAL
Intervention: Housing First model (immediate access to scattered site housing and mental health support services)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Housing First model
Number of subjects: 575
Study: 28179255

Group type: COMPARATOR
Intervention: Placebo (PL) + l-NAME
Number of subjects: 14

Group type: COMPARATOR
Intervention: Losartan (LOS) + l-NAME
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Manidipine (MANI) + l-NAME
Number of subjects: 14
Study: 25592198

Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity (LTPA)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Home-based exercise training
Number of subjects: 539

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 539
Study: 23919898

Group type: EXPERIMENTAL
Intervention: Risperidone (3-12 mg/day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Olanzapine (10-40 mg/day)
Number of subjects: 42
Study: 21481517

Group type: COMPARATOR
Intervention: 2005 guidelines
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 2000 ERC guidelines hand position modification
Number of subjects: 82
Study: 19036070

Group type: EXPERIMENTAL
Intervention: Dalteparin (n = 58)
Number of subjects: 116
Study: 17197279

Group type: EXPERIMENTAL
Intervention: $50 bonus for accurate diet recalls on the first two of four recalls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: $50 bonus for the last two recalls
Number of subjects: 0

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 0
Study: 14735129

Group type: EXPERIMENTAL
Intervention: High-dose (2.5 x seizure threshold) bilateral (BL) ECT
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High-dose (6 x seizure threshold) RUL ECT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low (1.5 x seizure threshold) RUL ECT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Moderate (2.5 x seizure threshold) RUL ECT
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bilateral (BL) ECT
Number of subjects: 54

Group type: COMPARATOR
Intervention: RUL ECT (all doses)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: EEG measures
Number of subjects: 54
Study: 11179154

Group type: EXPERIMENTAL
Intervention: Educational intervention with two individual treatment sessions and two telephone follow up calls, supported by a comprehensive educational pack.
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standardised medical care (control group).
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Minimum intervention group (no further treatment).
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Telephone intervention group (additional seven follow up calls).
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Maximum intervention group (additional seven face to face sessions over four months).
Number of subjects: 148
Study: 9756807

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation
Number of subjects: 185

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 185
Study: 8118539

Group type: EXPERIMENTAL
Intervention: Albuterol treatment (two puffs from a metered-dose inhaler with spacer at 20-minute intervals)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo treatment (two puffs from a metered-dose inhaler with spacer at 20-minute intervals)
Number of subjects: 42
Study: 3562541

Group type: EXPERIMENTAL
Intervention: Weighted belt worn around the pelvis
Number of subjects: 20

Group type: COMPARATOR
Intervention: No weighted belt (control condition)
Number of subjects: 20
Study: 29909782

Group type: EXPERIMENTAL
Intervention: Endoscopic push-through technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Microscopic underlay technique
Number of subjects: 56
Study: 26777322

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Prasugrel 30 mg
Number of subjects: 300

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 300
Study: 25702740

Group type: EXPERIMENTAL
Intervention: Iron reduction intervention
Number of subjects: 0
Study: 24299257

Group type: EXPERIMENTAL
Intervention: Early physical therapy intervention (ePT) consisting primarily of manual therapy, exercise, and modalities.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual podiatric care (uPOD) consisting primarily of a stretching handout, medication, injections, and orthotics.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early physical therapy intervention (ePT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual podiatric care (uPOD)
Number of subjects: 0
Study: 17072024

Group type: EXPERIMENTAL
Intervention: Adult kayakers
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Young kayakers
Number of subjects: 76
Study: 12850362

Group type: EXPERIMENTAL
Intervention: Group B streptococcal type III CPS-TT conjugate vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10717782

Group type: EXPERIMENTAL
Intervention: One implant of MENT acetate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Two implants of MENT acetate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Four implants of MENT acetate
Number of subjects: 15
Study: 7794709

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 17
Study: 1718693

Group type: EXPERIMENTAL
Intervention: Gallopamil (50mg 3 times daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nifedipine (20mg 3 times daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Gallopamil (100mg twice daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nifedipine (20mg twice daily)
Number of subjects: 54
Study: 6152885

Group type: EXPERIMENTAL
Intervention: Intercostal nerve blockades (ICB) with 18-28 ml of plain bupivacaine 0.5% (1.30-1.82 mg kg-1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intercostal nerve blockades (ICB) with bupivacaine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 26
Study: 29979283

Group type: COMPARATOR
Intervention: Traditional Straight Set (TS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Agonist-Antagonist Paired Set (PS)
Number of subjects: 12
Study: 31556793

Group type: EXPERIMENTAL
Intervention: Conjoint analysis
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Rating scale
Number of subjects: 194

Group type: COMPARATOR
Intervention: Time tradeoff
Number of subjects: 194
Study: 28138734

Group type: EXPERIMENTAL
Intervention: IMD enriched with EPA, GLA, and antioxidants
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard isocaloric, isonitrogenous diet (control group)
Number of subjects: 87
Study: 25956274

Group type: EXPERIMENTAL
Intervention: Propofol with alfentanyl
Number of subjects: 51

Group type: COMPARATOR
Intervention: Midazolam with alfentanyl
Number of subjects: 51
Study: 23448107

Group type: COMPARATOR
Intervention: Individual Education (IE)
Number of subjects: 623

Group type: COMPARATOR
Intervention: Group Education (GE)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Usual Care (UC)
Number of subjects: 623
Study: 21270204

Group type: EXPERIMENTAL
Intervention: Pancreatic fat fraction (PFF) in Hispanics
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Pancreatic fat fraction (PFF) in males
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Correlation of PFF with VAT
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Correlation of PFF with HFF
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Correlation of PFF with FFA
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Correlation of PFF with inflammatory markers
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Predictors of PFF
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Correlation of PFF with insulin sensitivity and β-cell function
Number of subjects: 138
Study: 18029219

Group type: EXPERIMENTAL
Intervention: Elastic lumbar support (orthosis)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no orthosis)
Number of subjects: 29
Study: 16965523

Group type: EXPERIMENTAL
Intervention: Test toothpaste containing 0.24% sodium monofluorophosphate, 0.3% triclosan, and 2% polyvinyl‐methyl ether maleic acid
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control toothpaste containing 0.76% sodium monofluorophosphate and 0.1% sodium fluoride
Number of subjects: 34
Study: 14979610

Group type: EXPERIMENTAL
Intervention: MLBL (immunostimulating therapy) - one sublingual tablet per day for 10 consecutive days per month for 3 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo - one sublingual tablet of taste masked placebo per day for 10 consecutive days per month for 3 months
Number of subjects: 47
Study: 11135021

Group type: EXPERIMENTAL
Intervention: Sumatriptan, 50 mg
Number of subjects: 249
Study: 9291760

Group type: EXPERIMENTAL
Intervention: Portex introducer
Number of subjects: 89

Group type: COMPARATOR
Intervention: No introducer
Number of subjects: 89
Study: 8361862

Group type: EXPERIMENTAL
Intervention: Generic verapamil (one specific generic product)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Brand-name verapamil
Number of subjects: 16
Study: 3089941

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 2 g b.i.d. for ten days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 2 g b.i.d. and metronidazole 0.8 g b.i.d. for ten days
Number of subjects: 20
Study: 29659896

Group type: EXPERIMENTAL
Intervention: Metformin 2000 mg daily
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 27106005

Group type: EXPERIMENTAL
Intervention: Immediate second resection of the tumor bed after complete TUR (Group I)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Delayed second TURB (Group II)
Number of subjects: 47
Study: 24100619

Group type: EXPERIMENTAL
Intervention: Socio-demographic + falls risk factors
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Socio-demographic + falls risk factors + functional measures
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Unable to rise from a chair of knee height
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Lower household income
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Using a walking aid
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Difficulty in using public transport
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Poorer physical health
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Black/minority ethnic group
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Self-reported balance problems
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Lower educational level
Number of subjects: 1088

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 1088
Study: 21375564

Group type: EXPERIMENTAL
Intervention: Information provided to mothers about teething symptoms and management (3 rounds of printed information at enrolment, 6 months, and 12 months)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 441
Study: 20718183

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (0.3 g/kg/day for seven days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19150030

Group type: EXPERIMENTAL
Intervention: Self-reported food allergy prevalence
Number of subjects: 3099

Group type: EXPERIMENTAL
Intervention: Allergen types
Number of subjects: 3099

Group type: EXPERIMENTAL
Intervention: Symptoms of food allergy
Number of subjects: 3099

Group type: EXPERIMENTAL
Intervention: Atopic diseases association
Number of subjects: 3099
Study: 17273676

Group type: EXPERIMENTAL
Intervention: Cyclopsorin 0.05%
Number of subjects: 20
Study: 14636103

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation (30 g/day for the first 2 weeks, 15 g/day for the final 2 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11276624

Group type: EXPERIMENTAL
Intervention: High-dose IFN alpha-2b
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low-dose IFN alpha-2b
Number of subjects: 16

Group type: COMPARATOR
Intervention: No therapy (control)
Number of subjects: 16
Study: 8860710

Group type: EXPERIMENTAL
Intervention: Double filtration plasmapheresis (DFPP)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Thermofiltration (TFPP)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Low-density lipoprotein adsorptive (PA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: DFPP and TFPP
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: All methods (DFPP, TFPP, PA)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: DFPP
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: TFPP and PA
Number of subjects: 5
Study: 1520109

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.3% tobramycin
Number of subjects: 0
Study: 6404192

Group type: EXPERIMENTAL
Intervention: Fenoterol (200 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: DSCG (20 mg)
Number of subjects: 12
Study: 31774713

Group type: EXPERIMENTAL
Intervention: Health worker breast health training at intervention HCs
Number of subjects: 1792
Study: 28768848

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (specific agents not detailed, but includes aspirin-clopidogrel)
Number of subjects: 43112

Group type: EXPERIMENTAL
Intervention: S 2 TOP-BLEED score
Number of subjects: 43112

Group type: EXPERIMENTAL
Intervention: External validation of S 2 TOP-BLEED score
Number of subjects: 43112
Study: 26647104

Group type: EXPERIMENTAL
Intervention: Behavioral counseling assistance plus self-generated messages
Number of subjects: 24

Group type: COMPARATOR
Intervention: Self-generated messages only
Number of subjects: 24
Study: 25111348

Group type: EXPERIMENTAL
Intervention: Multisource phase-controlled radiofrequency (MPCRF) treatment on the treated side of the face
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated side of the face (control)
Number of subjects: 10
Study: 22514257

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 19410683

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 10001